Klingbeil American Medical Fund LLC - 94111 San Francisco, CA

Business Name: Klingbeil American Medical Fund LLC
Categorized In:
Address: 615 Front St, San Francisco, CA 94111
Phone Number: (415) 398-3590
Contact Person: James Klingbeil Jr
Website Address: kmpre.com
NAICS Code: 531110
SIC Code: 6798
Business Type: B2B & B2C
Founding Year: 2010
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $1.000.000 to $2.499.999
Share This Business:
Similar Businesses: Miref Mission Heritage LLC - San Francisco, CA 94111
811 Sw Naito Associates LLC - San Francisco, CA 94111
Aphelion Capital LLC - San Francisco, CA 94111
Fidelity Cap V LLC - San Francisco, CA 94111
One Embarcadero Center Venture - San Francisco, CA 94111
Rreef Usa Fund Ii - San Francisco, CA 94111
Sfers Real Estate Corp Ff - San Francisco, CA 94111
Mcmorgan Institutional Real Estate Fund I LLC - San Francisco, CA 94111
Fjm Investments LLC - San Francisco, CA 94111
Prologis Lp - San Francisco, CA 94111
300 California Associates LLC - San Francisco, CA 94111
Digital Realty Trust Inc - San Francisco, CA 94111
Mac Donald Commercial Rl Est - San Francisco, CA 94111
Page Street Properties - San Francisco, CA 94111
Eastern Light Capital Incorporated - San Francisco, CA 94111
Amb Euro Invest LLC - San Francisco, CA 94111
Redevelopment Assoc LLC - San Francisco, CA 94111

Klingbeil American Medical Fund LLC provides professional from its single location at the coordinates .

The company offers BOTH variables under the SIC code 6798 and NAICS code 531110, while making an annual revenue of $1.000.000 to $2.499.999 and hiring a total of 1 to 4 employees.

Founded in 2010, the company can now be visited at 615 Front St, San Francisco, California 94111 or contacted through representative James Klingbeil Jr at (415) 398-3590.

For frequently asked questions and further inquiries about professional , get to know more about Klingbeil American Medical Fund LLC through its company website at kmpre.com. Engage with this business on its social media platforms through on Twitter and on Facebook.